A pain-relieving gel in the pipeline for treating migraine appears safe and effective, and may provide a new treatment option after further testing. Continue Reading
I had headaches most of my childhood, but never had a migraine until I was 33. By this time I had two children, the youngest was 4-years old, and I hadn’t been sick since I was a kid. At first the migraines were just 5-6 a month, around my period. I talked to my gynecologist, who told me to see a neurologist, but thankfully gave me some Maxalt to get by on until then. When I took it the first time I thought it was a miracle! Continue Reading
Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is indicated for rheumatoid arthritis and osteoarthritis but has also proven to reduce migraine intensity and frequency.
Flurbiprofen can be taken intermittently to treat a headache attack. One study indicated that the efficacy of flurbiprofen in migraine prevention may be comparable with that reported in studies with propranolol, verapamil and naproxen sodium. As with all NSAIDs, gastro-intestinal side effects, such as nausea, abdominal pain or bleeding ulcers, may occur.
Ketorloac is a nonsteroidal anti-inflammatory drug (NSAID) in both injectable and oral form that has been found to be as effective as a narcotic in treating severe headache pain. NSAIDs are effective in treating acute headaches and they are not habit forming. However, as a class these agents can cause nausea and stomach distress. Even Ketorloac as an injection has this side effect potential. Gastrointestinal bleeding or stomach ulcers can occur. Long-term use can contribute to kidney damage.
Ketorloac injection is frequently chosen for patients in the emergency room presenting with severe headache. Ketorloac tablets should be used for only short-term treatment (i.e., about five days)and are less effective than the injectable forms.